Black Diamond Therapeutics, Inc.
BDTX
$1.62
$0.021.25%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 98.58M | 112.68M | 122.97M | 115.20M | 131.40M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.60M | 2.86M | 3.78M | 3.61M | 2.63M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 101.18M | 115.54M | 126.75M | 118.81M | 134.03M |
|
|||||
Total Current Assets | 101.18M | 115.54M | 126.75M | 118.81M | 134.03M |
Net Property, Plant & Equipment | 20.40M | 21.24M | 22.07M | 22.90M | 23.71M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.07M | 1.12M | 1.16M | 819.00K | 823.00K |
Total Assets | 122.64M | 137.90M | 149.99M | 142.52M | 158.57M |
|
|||||
Total Accounts Payable | 4.01M | 1.97M | 763.00K | 1.18M | 2.32M |
Total Accrued Expenses | 13.16M | 15.50M | 14.42M | 12.49M | 14.21M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.40M | 3.33M | 3.26M | 3.18M | 3.11M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 20.57M | 20.80M | 18.44M | 16.85M | 19.65M |
|
|||||
Total Current Liabilities | 20.57M | 20.80M | 18.44M | 16.85M | 19.65M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 18.78M | 19.67M | 20.53M | 21.36M | 22.19M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 39.36M | 40.47M | 38.97M | 38.22M | 41.83M |
|
|||||
Common Stock & APIC | 570.37M | 568.44M | 566.70M | 540.06M | 534.19M |
Retained Earnings | -487.11M | -471.12M | -455.57M | -435.66M | -417.43M |
Treasury Stock & Other | 24.00K | 107.00K | -115.00K | -95.00K | -27.00K |
Total Common Equity | 83.29M | 97.43M | 111.02M | 104.31M | 116.74M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 83.29M | 97.43M | 111.02M | 104.31M | 116.74M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 83.29M | 97.43M | 111.02M | 104.31M | 116.74M |
|